Intelligent Ultrasound has provided a trading update for the 12 months to December 2021. Revenues in the period are expected to be up 47% to £7.6m, with Simulation Division revenues of £7.4m (+44%) and early Clinical AI Division revenues of £0.2m (H1/21A £0.05m). Significantly, FY21 saw the group generate AI revenues from both its partnership with GE Healthcare and proprietary ScanNav Anatomy Peripheral Nerve Block (PNB) and NeedleTrainer devices. Management has provided a positive outlook on FY ....
13 Jan 2022
Cenkos: Intelligent Ultrasound Group Plc -- Trading update: Strong performance
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Intelligent Ultrasound Group Plc -- Trading update: Strong performance
Intelligent Ultrasound Group Plc (IUG:LON) | 8.8 0.1 8.2% | Mkt Cap: 28.6m
- Published:
13 Jan 2022 -
Author:
Chris Donnellan -
Pages:
5
Intelligent Ultrasound has provided a trading update for the 12 months to December 2021. Revenues in the period are expected to be up 47% to £7.6m, with Simulation Division revenues of £7.4m (+44%) and early Clinical AI Division revenues of £0.2m (H1/21A £0.05m). Significantly, FY21 saw the group generate AI revenues from both its partnership with GE Healthcare and proprietary ScanNav Anatomy Peripheral Nerve Block (PNB) and NeedleTrainer devices. Management has provided a positive outlook on FY ....